Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
about
Gender differences in the effect of occupational endotoxin exposure on impaired lung function and death: the Shanghai Textile Worker StudyRelevant Outcomes in Pediatric Acute Respiratory Distress Syndrome StudiesInforming evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseasesOne year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trialIntroduction to the Analysis of Survival Data in the Presence of Competing RisksRisk factors for physical impairment after acute lung injury in a national, multicenter study.Clinical Trials in Veterinary Medicine: A New Era Brings New Challenges.Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study.Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.Metabolic syndrome and outcomes following early-stage breast cancer.Cumulative incidence of cancer after solid organ transplantationModelling competing risks in nephrology research: an example in peritoneal dialysis.Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.Semicompeting risks in aging research: methods, issues and needs.Associations between diabetes medication use and risk of second breast cancer events and mortalityFront-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysisProtocol for a randomised controlled trial of standard wound management versus negative pressure wound therapy in the treatment of adult patients with an open fracture of the lower limb: UK Wound management of Open Lower Limb Fractures (UK WOLFF)Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991-2011Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japanese multicentre rheumatoid arthritis registry.Competing risks and the clinical community: irrelevance or ignorance?Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research.Association of Opioids with Falls, Fractures, and Physical Performance among Older Men with Persistent Musculoskeletal PainBreast cancer recurrence in relation to antidepressant use.Occupational therapy for patients with acute lung injury: factors associated with time to first intervention in the intensive care unitFrequent antibiotic use and second breast cancer events.Risk of fatal cerebrovascular accidents after external beam radiation therapy for early-stage glottic laryngeal cancer.Commentary: Back to the future with Sir Bradford Hill: statistical analysis with hospital-acquired infections.Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up.Factors associated with timing of initiation of physical therapy in patients with acute lung injury.Developing points-based risk-scoring systems in the presence of competing risks.Background and design of the profiling biobehavioral responses to mechanical support in advanced heart failure study.Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocolRisk factors of CVD mortality among the elderly in Beijing, 1992 - 2009: an 18-year cohort study.Physical complications in acute lung injury survivors: a two-year longitudinal prospective study.Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.How outcomes are defined in clinical trials of mechanically ventilated adults and children.Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-Medicare population.Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study.
P2860
Q23919376-11CB2E1B-B7A1-447D-A8D4-3B57C471D823Q26744504-C6ED763D-A2B7-4E5E-920F-B1313D65C4A4Q27023214-12344C42-9468-4188-A31E-A6EFF44E506FQ30421818-52A320C0-2920-4538-9FBB-C8572AF8D6B9Q31043722-DB203CCF-C719-47BA-AC9A-C86FAC63820BQ33772265-6567FCF0-2BCA-431E-AACB-7CEECE117984Q33900204-4F35E810-ED21-4819-92DA-3DF12DB43A3BQ34343656-02513213-B4B8-4E6C-BDD1-B5358EA9BAFEQ34418562-935B2BE4-6876-4A95-B09E-D1CCF12B993BQ34539016-6E21C5F4-144D-4C53-8013-84C19267886BQ34561525-0382C607-685F-424E-A274-9735125235AEQ34738940-C0B54AD1-3906-4D6E-94A4-A8F0FB69503FQ35051231-180C86A1-615A-42E7-AD05-74D65F5B2516Q35601731-F5781226-2FBD-4697-8487-16FEA9AA3938Q35850213-917094D1-468A-4809-9A9E-7CE003995B7FQ35961843-5D77F5A1-B5B5-422A-BA19-682B4618131CQ36120542-90558857-372E-49A4-9259-F190926A0F89Q36230189-DE721E63-2AD1-4FFB-B379-8C2A75A6680FQ36506140-3CE8E95F-7360-4EF1-9A50-D6E39CEF462BQ36573569-3FFD64A2-6D27-48D0-B94F-E2F14C7CC2BBQ36619420-43A2A22C-ECAB-4381-86E2-2F41D9952191Q36748799-AD9E5F11-1725-4FD8-8FA3-AF728D9151A9Q36808988-099B97B8-146C-43C1-88AF-5FF0B6E85EB6Q37020150-6099027A-6363-4AB2-8922-12715EA8E48BQ37043765-54FDE8BF-CBEC-4ACF-A888-3ECD52884801Q37161169-18CC5095-0878-4C22-BC46-632E57D0C91FQ37227986-6B6C517D-1C4B-487B-967F-EECC581C4584Q37253498-FE01E803-3538-4164-8D45-34F25E2A5234Q37307535-7D0F1707-8784-4516-920D-1B43F87A3F3AQ37315804-A3CE4A9E-D9E3-4558-BC3A-7B9971068DC3Q37375552-DD6618FD-DEB1-4C27-9BED-2BA5358227F9Q37452892-53B80B39-DDB9-4573-B2C6-3E36E86567E6Q37527133-755C9C46-2B39-4B9A-9F22-15D3E36B7677Q37623071-334F55D1-6477-4C5D-ACAF-4A6A4FCF4FE8Q37646839-A25D24B1-FB81-464E-AE18-FA239C7629F1Q37705334-5FA5E4C2-12C7-4602-9D39-9476EBAF2698Q38068890-39D8689C-4FAC-4A0B-BA04-3E9EDA7269EBQ38186788-F3912208-6122-47AC-87A5-C32747DE6890Q38625054-342CE753-E1EB-47CC-88EE-F6DBFC6CEF4FQ38664434-B56CE326-C81F-4745-B606-5F2AF8AF18EC
P2860
Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluating health outcomes in ...... ods and clinical applications.
@en
Evaluating health outcomes in ...... ods and clinical applications.
@nl
type
label
Evaluating health outcomes in ...... ods and clinical applications.
@en
Evaluating health outcomes in ...... ods and clinical applications.
@nl
prefLabel
Evaluating health outcomes in ...... ods and clinical applications.
@en
Evaluating health outcomes in ...... ods and clinical applications.
@nl
P2093
P1433
P1476
Evaluating health outcomes in ...... ods and clinical applications.
@en
P2093
Albert W Wu
Carlos O Weiss
Cynthia Boyd
Daniel Scharfstein
Jodi B Segal
Ravi Varadhan
P304
P356
10.1097/MLR.0B013E3181D99107
P433
P577
2010-06-01T00:00:00Z